-

World Economic Forum Recognizes Agilent Facility in Singapore as a Leader in Advanced Manufacturing

The manufacturing site joins an exclusive list of facilities recognized for leveraging digital technology to increase performance while improving sustainability

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the World Economic Forum’s Global Lighthouse Network has named Agilent’s facility in Singapore a Fourth Industrial Revolution (4IR) leader for effectively deploying innovative technologies at scale in the manufacture of scientific instruments.

“Because of the incredible work of our team in Singapore, Agilent is among the leading manufacturers in our sector,” said Mike McMullen, president and CEO of Agilent. “We’re doing this for our customers, but also to provide a rewarding experience for our employees and to protect the environment.”

The Lighthouse is an initiative of the World Economic Forum in partnership with McKinsey & Company to showcase models of smart manufacturing enabled by 4IR technologies such as artificial intelligence and machine learning, robotics, data analytics, and the industrial internet of things.

By embracing 4IR technologies, Agilent’s Singapore facility has optimized productivity by 60% and increased output by 80%, all while advancing environmental sustainability through increased efficiency and greater reliance on renewable energy.

“We’re proud to receive this prestigious recognition, and we hope that others will be inspired to achieve their own technological breakthroughs on their 4IR journeys,” said Chow Woai Sheng, Agilent vice president of global instrument manufacturing and Singapore general manager. “This work also supports the government of Singapore’s Smart Nation Plan to spur economic growth through investment in digital technology.”

Agilent is deploying advanced digital technologies throughout its 28 manufacturing, operations and logistical sites across the world. These initiatives also contribute to Agilent’s goal of achieving net-zero greenhouse gas emissions by 2050.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward advancing the quality of life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.32 billion in fiscal 2021 and employs 17,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

Contacts

Media Relations, South Asia Pacific
Grace Thong
Agilent Technologies
+65 9688 2152
grace.thong@agilent.com

Global media relations
Sarah Litton
Agilent Technologies
+1 669 255 7696
sarah.litton@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Versions

Contacts

Media Relations, South Asia Pacific
Grace Thong
Agilent Technologies
+65 9688 2152
grace.thong@agilent.com

Global media relations
Sarah Litton
Agilent Technologies
+1 669 255 7696
sarah.litton@agilent.com

Social Media Profiles
More News From Agilent Technologies Inc.

Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Boehringer Ingelheim has been selected as the winner of Agilent’s inaugural Instrument Trade‑In Impact Award, recognizing exceptional sustainability leadership demonstrated through their participation in Agilent’s trade‑in and buyback program. The annual award honors the global partner that achieves the highest sustainability impact by diverting end‑of‑life laboratory instruments from landfill and con...

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved PD-L1 IHC 22C3 pharmDx, Code SK006, as the only FDA-approved companion diagnostic indicated to aid in identifying first-line patients with epithelial ovarian, fallopian tube, or primary peritoneal carcinoma (EOC), whose tumors express PD-L1 and who may be eligible for treatment with KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy. PD-L1 IHC...

Agilent Showcases Next‑Generation Automated Solutions at SLAS2026

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today that it will present a range of next‑generation automated workflow innovations at the SLAS2026 International Conference & Exhibition, taking place February 7–11 in Boston, Massachusetts. Agilent will demonstrate how its expanding automation ecosystem—integrating advanced imaging, software, robotics, and AI‑powered optimization—supports laboratories in accelerating discovery with confidence, efficiency,...
Back to Newsroom